LoginSignup
Insulet logo

Insulet Stock

StockStock
ISIN: US45784P1012
Ticker: PODD
US45784P1012
PODD

Price

Frequently asked questions

What is Insulet's market capitalization?

The market capitalization of Insulet is $16.17B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Insulet's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Insulet is 42.60. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Insulet?

Insulet's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.412. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Insulet's stock?

Currently, 21 analysts cover Insulet's stock, with a consensus target price of $232.74. Analyst ratings provide insights into the stock's expected performance.

What is Insulet's revenue over the trailing twelve months?

Over the trailing twelve months, Insulet reported a revenue of $1.87B.

What is the EBITDA for Insulet?

Insulet's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $348.20M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Insulet?

Insulet has a free cash flow of $182.40M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Insulet's stock?

The 5-year beta for Insulet is 1.22. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Insulet have, and what sector and industry does it belong to?

Insulet employs approximately 3,000 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Insulet's shares?

The free float of Insulet is 69.88M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $16.17B

5Y beta

 1.22

EPS (TTM)

 $5.412

Free Float

 69.88M

P/E ratio (TTM)

 42.60

Revenue (TTM)

 $1.87B

EBITDA (TTM)

 $348.20M

Free Cashflow (TTM)

 $182.40M

Pricing

1D span
$226.93$231.77
52W span
$151.56$243.98

Analyst Ratings

The price target is $232.74 and the stock is covered by 21 analysts.

Buy

18

Hold

3

Sell

0

Information

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

3,000

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US45784P1012

Primary Ticker

PODD

Knockouts

Join the conversation
Sign upLogin